EurekAlert! Cancer Research - News Releases

News Releases

Updates every hour. Last Updated: 22-Jun-2026 18:16 ET (22-Jun-2026 22:16 GMT/UTC)

Growth of spreading pancreatic cancer fueled by 'under-appreciated' epigenetic changes

Johns Hopkins Medicine
Peer-Reviewed Publication

In a lab-grown cell study focused on potential new treatment targets for halting the spread of most pancreatic cancers, Johns Hopkins Medicine scientists report they have found that a gene called KLF5 (Krueppel-like factor 5) fuels the growth of such spreading tumors not by acquiring abnormal changes in the cancer cells’ DNA code itself but by altering chemical changes and organization of DNA, or epigenetics, that turns genes on and off

Journal: Molecular Cancer
Funder: National Institutes of Health, Celgene License Pathway Agreement, A gift from the friends and family of Jasmine Lampadarios.

University of South Alabama Research named Top 10 Scientific Breakthroughs of 2025

University of South Alabama
Grant and Award Announcement

Dr. Simon Grelet, with the University of South Alabama's Mitchell Cancer Institute, has identified a novel mechanism by which neurons transfer mitochondria — the cell’s energy-producing structures — to cancer cells. This interaction fuels cancer metastasis and opens new possibilities for therapeutic intervention.

UCalgary study investigates the use of a common vitamin to treat the aggressive brain cancer glioblastoma

University of Calgary
Peer-Reviewed Publication

University of Calgary researchers have designed a study to investigate whether high doses of vitamin B3 or niacin could rejuvenate compromised immune cells to kill glioblastoma tumour cells. The clinical trial was designed to determine the maximum dose and potential benefit of controlled-release niacin that could be added to the recommended chemotherapy and radiotherapy treatments.

Journal: Neuro-Oncology
Funder: Alberta Cancer Foundation, Canadian Institutes of Health Research

New nanoparticles enable melanoma tumors to be removed with low-power laser light

Oregon State University
Peer-Reviewed Publication

Researchers at Oregon State University have developed and tested in a mouse model a new type of nanoparticle that enables the removal of melanoma tumors with a low-power laser.

Journal: Advanced Functional Materials
Funder: Eunice Kennedy Shriver National Institute of Child Health and Human Development

GLP-1 receptor agonists plus progestins and endometrial cancer risk in nonmalignant uterine diseases

JAMA Network
Peer-Reviewed Publication

About The Study: In this cohort study of women with benign uterine pathology or endometrial hyperplasia, combined glucagon-like peptide-1 receptor agonist (GLP-1RA) and progestin was associated with reduced endometrial cancer risk. Further investigation is warranted to assess its applicability and underlying mechanisms.

Journal: JAMA Network Open

Discovery of unique brain tumor subtypes offers hope for targeted glioma therapies

The Hospital for Sick Children
Peer-Reviewed Publication

SickKids researchers identify three subtypes of high-grade gliomas with distinct treatment responses to provide precision care for patients.

Journal: Nature Genetics

University of Missouri conducts first in-person clinical trial for nuclear medicine breakthrough device

University of Missouri-Columbia
Business Announcement

In a major leap for cancer care at the University of Missouri, the School of Medicine and MU Health Care have launched their first clinical trial using a leading-edge therapy manufactured on campus at the university’s research reactor. The achievement also showcases the breadth of research capabilities across campus to bring a radiopharmaceutical from development, through testing, to human clinical trials.

Eva Vailionis, MS, CGC is presented the 2026 ACMG Foundation Genetic Counselor Best Abstract Award by The ACMG Foundation

American College of Medical Genetics and Genomics
Grant and Award Announcement

Eva Vailionis, MS, CGC is the 2026 recipient of the ACMG Foundation Genetic Counselor Best Abstract Award. The ACMG Foundation for Genetic and Genomic Medicine selected Ms. Vailionis based on her abstract, “Prevalence and Tumor Characteristics of Patients with TMEM127 Pathogenic Variants in a Large, Pan-Cancer Cohort,” which will be delivered as a featured platform presentation at the 2026 ACMG Annual Clinical Genetics Meeting.

New dual-action compound reduces pancreatic cancer cell growth

Impact Journals LLC
Peer-Reviewed Publication

BUFFALO, NY — February 10, 2026 — A new research paper was published in Volume 13 of Oncoscience on January 28, 2026, titled “Dual targeting of oncogenic microtubules and mitochondria in PDAC.”

Journal: Oncoscience

Researchers discover genetic link to Barrett’s esophagus offering new hope for esophageal cancer patients

Case Western Reserve University
Peer-Reviewed Publication

CWRU researchers have discovered how inherited genetic abnormalities increase the chance of developing Barrett's esophagus by weakening the esophageal lining, making it more susceptible to harm caused by stomach bile acid.

Journal: Nature Communications